News Industry News New RE-VERSE AD™ Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery November 14, 2017
News Conference News AHA 2017 AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More Shelley Wood November 09, 2017
Presentation TCT 2017 When Bleeding Occurs on Warfarin or NOAC: Reversal Strategies Presenter: Robert A. Harrington, Kurt Huber, Michael D. Ezekowitz November 01, 2017
Presentation TCT 2017 Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy Presenter: Thomas H. Maloney, C. Michael Gibson October 30, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2017 Shelley Wood October 29, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2017 Shelley Wood September 30, 2017
Presentation LAA 2017 Warfarin and NOACs in Non-Valvular Atrial Fibrillation Presenter: Gregg W. Stone July 21, 2017
News Daily News Study Suggests VKA Monotherapy Sufficient in Patients With A-fib but No CAD Yael L. Maxwell June 20, 2017
News Daily News Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI L.A. McKeown May 23, 2017
News Daily News Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women Todd Neale May 11, 2017
News Daily News More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds Todd Neale May 05, 2017
News Daily News ‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum Todd Neale April 27, 2017
News Daily News Do NOACs Carry a Higher Risk of Acute MI? New Study Reopens Old Questions Todd Neale March 28, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
Presentation New Oral Anticoagulants: Are the Best Options Presenter: Roberta Rossini February 10, 2017